News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
391,250 Results
Type
Article (15434)
Company Profile (117)
Press Release (375699)
Section
Business (121568)
Career Advice (461)
Deals (20771)
Drug Delivery (27)
Drug Development (35660)
Employer Resources (49)
FDA (9723)
Job Trends (8014)
News (190345)
Policy (14502)
Tag
Academia (1343)
Alliances (37657)
Alzheimer's disease (541)
Approvals (9737)
Artificial intelligence (183)
Bankruptcy (135)
Best Places to Work (6701)
Biotechnology (91)
Breast cancer (96)
Cancer (837)
Career advice (411)
CAR-T (76)
Cell therapy (212)
Clinical research (28164)
Collaboration (472)
Compensation (81)
COVID-19 (1182)
C-suite (93)
Data (784)
Diabetes (70)
Diagnostics (4919)
Drug discovery (67)
Earnings (41764)
Events (53978)
Executive appointments (315)
FDA (10191)
Funding (383)
Gene editing (66)
Gene therapy (135)
GLP-1 (216)
Government (1342)
Healthcare (10228)
Infectious disease (1242)
IPO (8634)
Job creations (1600)
Job search strategy (367)
Layoffs (118)
Legal (3171)
Lung cancer (113)
Manufacturing (141)
Medical device (11536)
Medtech (11541)
Mergers & acquisitions (12390)
Metabolic disorders (167)
Neuroscience (693)
NextGen: Class of 2025 (3606)
Non-profit (1543)
Northern California (892)
Obesity (80)
Opinion (72)
Patents (86)
People (34407)
Phase I (9887)
Phase II (12484)
Phase III (8647)
Pipeline (321)
Postmarket research (681)
Preclinical (4319)
Radiopharmaceuticals (157)
Rare diseases (126)
Real estate (3641)
Regulatory (10667)
Research institute (1300)
Resumes & cover letters (68)
Series A (70)
Southern California (950)
Startups (2624)
United States (9349)
Vaccines (273)
Date
Today (88)
Last 7 days (328)
Last 30 days (1645)
Last 365 days (19587)
2025 (1709)
2024 (19942)
2023 (23456)
2022 (32666)
2021 (34452)
2020 (32789)
2019 (27318)
2018 (20656)
2017 (20337)
2016 (19088)
2015 (22301)
2014 (16731)
2013 (14135)
2012 (15237)
2011 (15581)
2010 (14220)
Location
Africa (349)
Arizona (110)
Asia (33266)
Australia (4996)
California (2298)
Canada (945)
China (234)
Colorado (131)
Connecticut (113)
Europe (53849)
Florida (356)
Georgia (106)
Illinois (241)
Indiana (127)
Japan (90)
Kansas (78)
Maryland (386)
Massachusetts (1624)
Michigan (167)
Minnesota (217)
New Jersey (758)
New York (672)
North Carolina (466)
Northern California (892)
Ohio (86)
Pennsylvania (468)
South America (560)
Southern California (950)
Texas (349)
Utah (77)
Washington State (278)
391,250 Results for "chemotech technologies ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award, sponsored by InterSystems.
June 12, 2024
·
5 min read
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.
July 1, 2024
·
5 min read
Business
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, reported its financial results for the fiscal year ended December 31, 2023.
April 24, 2024
·
14 min read
Press Releases
BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB
January 8, 2025
·
1 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
WORK Medical Technology Group LTD Announces Pricing of Initial Public Offering
August 26, 2024
·
5 min read
Press Releases
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
January 24, 2025
·
5 min read
1 of 39,125
Next
